PLoS ONE 9(6):e101005 De Marinis YZ, Salehi A, Ward CE, Zhang Q, Abdulkader F, Bengtsson M et al (2010) GLP-1 inhibits and adrenaline stimulates glucagon release by differential modulation of N- and L-type Ca2+ channel-dependent exocytosis
January 14, 2025
Even small amounts of food, beverages other than water, or other medications can interfere with absorption
This hormonal interplay means that two patients using identical microdosing amounts may experience very different outcomes based on their unique hormonal profiles, underscoring the importance of individualized dosing and close monitoring
#FDAApproval #ObesityManagement #GLP1 #ClinicalPharmacology #NewDrugApproval #WeightManagement #HealthcareInnovation #MedicalEducation #Orforglipron #Foundayo To view or add a comment, sign in Just as employers start to get their arms around GLP-1 costs the next wave is already hereand its more powerful
The comparison between semaglutide and tirzepatide becomes relevant here, as the two medications may produce different rates of weight loss in different individuals, and choosing the one that produces a more gradual trajectory could be hair-protective